Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D.
Wakabayashi Y, Telu S, Dick RM, Fujita M, Ooms M, Morse CL, Liow JS, Hong JS, Gladding RL, Manly LS, Zoghbi SS, Mo X, D'Amato EC, Sindac JA, Nugent RA, Marron BE, Gurney ME, Innis RB, Pike VW. Wakabayashi Y, et al. ACS Chem Neurosci. 2020 May 6;11(9):1311-1323. doi: 10.1021/acschemneuro.0c00077. Epub 2020 Apr 8. ACS Chem Neurosci. 2020. PMID: 32212718 Free PMC article.
PDE4 subtypes in cancer.
Hsien Lai S, Zervoudakis G, Chou J, Gurney ME, Quesnelle KM. Hsien Lai S, et al. Oncogene. 2020 May;39(19):3791-3802. doi: 10.1038/s41388-020-1258-8. Epub 2020 Mar 20. Oncogene. 2020. PMID: 32203163 Free PMC article. Review.
Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders.
Gurney ME, Nugent RA, Mo X, Sindac JA, Hagen TJ, Fox D 3rd, O'Donnell JM, Zhang C, Xu Y, Zhang HT, Groppi VE, Bailie M, White RE, Romero DL, Vellekoop AS, Walker JR, Surman MD, Zhu L, Campbell RF. Gurney ME, et al. J Med Chem. 2019 May 23;62(10):4884-4901. doi: 10.1021/acs.jmedchem.9b00193. Epub 2019 Apr 23. J Med Chem. 2019. PMID: 31013090 Free PMC article.